Ethnopharmacological Relevance: Unani remedies are considered safe and can be utilized as a healthcare resource due to the adverse effects of conventional pharmaceuticals. For instance, Donepezil, used to treat alzhemier's disease exerts many adverse effects such as dizziness, vertigo, dryness of mouth. Similarly, Memantine used to slow the neurotoxicity involved in alzhemier's disease also exerts adverse effects like vomiting, tremors and sleep disturbance. Over sixty percent of drugs are derived from synthetic basis, highlighting the potential benefits of natural Unani treatments as a safer alternative. Neurodegenerative disorders are illnesses characterized by structural and functional deterioration due to abnormal protein aggregation, resulting in inflammation and oxidative stress in the central nervous system. In unani system of medicine all current brain ailments, including alzheimer's disease, parkinson's disease, mania, anxiety, melancholia and others are classified under the general category of neurodegenerative disorders Their pathogenic variables and soociated symptoms and therapeutic modalities are similar. This study focuses on evidence-based Unani herbs and polyherbal formulations for the treatment of various neurodegenerative disorders. It reveals that 43 ethnomedicinal plants can be employed to treat the symptoms of neurodegenerative disorders. The material was gathered from several sources that tabulated the specific details of individual herbs and polyherbal formulations and highlighted the importance of various phytoconstituents on neuroprotective action. The research provides in vivo and scientific evidence to support the use of ethnomedicine in treating neurodegenerative disorders.

Aim Of The Study: This study aims to validate the efficacy of Unani medicines, traditionally used for neurodegenerative diorders through evidence-based research.

Methods: To scan single and polyherbal formulations for neurodegenerative disorders, a literature review of traditional Unani medicine texts was conducted. To collect evidence on the efficacy of these indicated medications in the treatment of neurodegenerative disorders, electronic resources such as ScienceDirect, PubMed, Wiley Online Library, and Google Scholar were searched. The current study is a systematic review that applies inclusion and exclusion criteria rooted in the classical symptoms of neurological disorders. It evaluates the efficacy of individual herbs and polyherbal formulations recommended by Unani scholars for treatment perspectives.

Results: The researchers have so far discovered 43 single drugs and 38 polyherbal formulations in Unani classical literature for treating various neurodegenerative disorders. These herbs have antioxidant, anti-Alzheimer's, anti-Parkinsonism, anti-convulsant, cognitive enhancer, anti-anxiety, neuroprotective, and anti-depressant properties, with clinical investigations proving their efficacy. The study exclusively focuses on systematic review, highlighting selected clinical studies to assess their quality and reliability of evidence. These are discussed in the introduction to provide context and understanding.

Conclusions: After a thorough review of entire literature of Unani medicine, it is evident that has painstakingly focused more on physiopathology of diseases of Dimāgh wa A'sāb including their treatment protocols .These protocols include Istifrāgh (biopurification), Taskhīn (producing warmth), Tajfiīf (desiccation), Tafrīħ-i Taba' (exhilaration). Research into Unani medicine has shown promising results, particularly in the use of medicinal plants known for their neuroprotective properties. One of the key advantages of Unani herbs is their natural composition, which typically consists of bioactive compounds that exert neuroprotective effects without the harsh impact often associated with synthetic drugs. For instance, herbs like Brahmi(Bacopa monnieri), Waj Turki (Acorus calamus), Chilghoza(Pinus gerardiana Wall) and Asgand (Withania somnifera) and many other plants have been studied for their ability to enhance cognitive function, reduce oxidative stress, and support neuronal health. These herbs work through various mechanisms such as antioxidant activity, anti-inflammatory properties, and modulation of neurotransmitter levels, all of which contribute to their neuroprotective potential. Nevertheless some of the compound formulations presented, that, have not yet undergone clinical testing. As a result, the researchers are advised to validate those medicines that have not yet undergone clinical evaluation.

Download full-text PDF

Source

Publication Analysis

Top Keywords

neurodegenerative disorders
32
polyherbal formulations
24
unani medicine
16
unani
12
adverse effects
12
herbs polyherbal
12
neurodegenerative
10
disorders
9
single drugs
8
drugs polyherbal
8

Similar Publications

The increasing global prevalence of Alzheimer's disease necessitates the development of novel therapeutic approaches. Neurodegenerative diseases are associated with increased oxidative stress and levels of cholinesterase enzymes. Hence, the development of cholinesterase inhibitors and antioxidants may provide neuroprotective effects.

View Article and Find Full Text PDF

Opsoclonus-myoclonus syndrome (OMS) is a rare neurological disorder characterized by a combination of main symptoms: opsoclonus, myoclonus, ataxia, psychoemotional and behavioral disturbances. OMS can develop in children as a result of immunopathological processes against the background of infectious or oncological pathology and lead to persistent neurological deficit. A case of ten-year observation of paraneoplastic OMS associated with neuroblastoma in a child is presented.

View Article and Find Full Text PDF

[A portrait of a doctor with Parkinson's disease].

Zh Nevrol Psikhiatr Im S S Korsakova

December 2024

Siberian State Medical University, Tomsk, Russia.

In a number of causes of Parkinson's disease (PD), occupation is periodically mentioned as a possible risk factor. However, a look at the complex impact of external factors on people of certain professions and the expansion of the area of risk factors in a rapidly changing world leads to the emergence of new studies. There is an assumption that the risk of developing PD is increased in doctors due to long-term exposure to stress.

View Article and Find Full Text PDF

Objective: Study of neuroimaging changes according to MRI morphometry and their comparison with the structure and severity of cognitive impairment (CI) in patients with Alzheimer's disease (AD) and primary open-angle glaucoma (POAG).

Material And Methods: The study involved 90 patients who were divided into two equal groups of 45 people and who early had diagnosis of AD (group 1; median age - 71 [66; 77] years) and POAG (group 2; median age - 68 [64; 77] years). 71] years).

View Article and Find Full Text PDF

Objective: To analyze the results of nocturnal breathing parameters during sleep based on nocturnal pulse oximetry and to study of characteristics of external respiration in genetically confirmed patients with dystrophic myotonia (DM).

Material And Methods: The subjects of the study were patients with genetically confirmed DM types 1 and 2 who were hospitalized in the neurological departments of the Republican Scientific and Practical Center for Neurology and Neurosurgery. The clinical picture of the disease, comorbidities, sleep questionnaires, laboratory tests, overnight pulse oximetry and spirometry were performed and analyzed.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!